V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011200 | 310004848 | 1.77 | 80.8 | Curative (C) | 2016-07-26 | 2017-01-19 | ALL UKALL2011 Aug BFM Cons C PegAsp | Y | N | 310019087 | CARBOPLATIN + ETOPOSIDE |
| 310011202 | 310004859 | 1.85 | 94.1 | null | null | 2016-08-12 | Etoposide oral | 02 | N | 310019130 | ETOPOSIDE |
| 310011203 | 310008095 | 1.73 | 93 | Palliative (P) | 2016-10-24 | 2016-10-24 | Bexarotene | N | N | 310019133 | CARBOPLATIN + ETOPOSIDE |
| 310011204 | 310008096 | 1.7 | 79.2 | Curative (C) | 2014-10-20 | 2014-11-17 | Methotrexate intrathecal | 02 | Y | 310019139 | METHOTREXATE INTRATHECAL |
| 310011205 | 310011265 | 1.81 | 96 | Palliative (P) | 2014-07-02 | 2014-07-26 | Docetaxel 75mg/m2 (21 day) | N | Y | 310019167 | DOCETAXEL |
| 310011206 | 310009813 | null | 73.1 | null | 2018-02-20 | 2018-08-09 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310019216 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011207 | 310004879 | 1.73 | 96.5 | Palliative (P) | 2016-07-25 | 2016-08-23 | Bexarotene | 02 | null | 310019225 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310011208 | 310004895 | 1.7 | 88.4 | Palliative (P) | 2014-10-06 | 2014-10-13 | Ipilimumab | 2 | N | 310019289 | IPILIMUMAB |
| 310011209 | 310004902 | null | 97.6 | Curative (C) | 2016-02-17 | 2016-06-22 | Cisplatin | 2 | N | 310019334 | CISPLATIN |
| 310011210 | 310004909 | 1.75 | 57 | Disease modification (D) | 2014-09-24 | 2016-03-20 | CYCLOPHOSPHAMIDE | N | N | 310019366 | CYCLOPHOSPHAMIDE |
| 310011211 | 310004912 | 1.55 | null | Curative (C) | 2013-10-19 | 2013-10-20 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019371 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011212 | 310008122 | 1.71 | 73 | Curative (C) | 2017-10-15 | 2017-11-06 | Cyclophosphamide High Dose | N | N | 310019376 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011213 | 310004920 | null | 64.8 | Curative (C) | 2016-10-08 | 2016-10-23 | Cyclophosphamide High Dose | N | N | 310019388 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011214 | 310008131 | 1.53 | 51.7 | Curative (C) | 2015-03-22 | 2015-03-30 | Cisplatin | N | N | 310019432 | CISPLATIN |
| 310011215 | 310004933 | null | 55.5 | Palliative (P) | 2016-03-18 | 2016-04-11 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 310019457 | DOCETAXEL + GEMCITABINE |
| 310011216 | 310004937 | 1.68 | 58.3 | Disease modification (D) | 2014-02-27 | 2014-03-13 | Rituximab | 02 | N | 310019463 | RITUXIMAB |
| 310011217 | 310004946 | 1.9 | 130 | Disease modification (D) | 2015-09-02 | 2015-09-03 | Rituximab | 02 | Y | 310019473 | RITUXIMAB |
| 310011218 | 310004951 | null | 124.9 | Curative (C) | null | 2018-06-25 | Cyclophosphamide High Dose | N | null | 310019477 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011219 | 310004956 | 1.77 | 61 | Disease modification (D) | 2017-12-01 | 2018-01-22 | Methotrexate intrathecal | N | null | 310019507 | METHOTREXATE INTRATHECAL |
| 310011220 | 310008146 | 1.53 | 69.3 | Palliative (P) | 2018-02-22 | 2018-03-12 | Ipilimumab | N | N | 310019511 | IPILIMUMAB |
| 310011222 | 310009837 | 1.7 | 52.4 | Palliative (P) | 2017-07-21 | 2017-08-02 | Ipilimumab | 2 | N | 310019551 | IPILIMUMAB |
| 310011223 | 310004970 | 1.55 | 52 | Curative (C) | 2016-05-09 | 2016-07-27 | Cyclophosphamide High Dose | 02 | N | 310019558 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011225 | 310009839 | 1.8 | 29.6 | Curative (C) | 2014-07-24 | 2014-07-25 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | null | 310019583 | DOCETAXEL + GEMCITABINE |
| 310011226 | 310010756 | 1.73 | 0 | Palliative (P) | 2018-02-13 | 2018-02-15 | Methotrexate intrathecal | 2 | N | 310019585 | METHOTREXATE INTRATHECAL |
| 310011227 | 310004983 | 1.68 | 76.5 | Palliative (P) | 2015-12-31 | 2016-01-19 | GDP | 2 | N | 310019610 | GDP |
| 310011228 | 310004996 | null | 50 | Palliative (P) | 2014-11-05 | 2015-04-19 | Cyclophosphamide High Dose | 1 | N | 310019675 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011229 | 310004998 | 1.6 | 52.3 | Palliative (P) | null | 2014-11-28 | ETOPOSIDE | null | null | 310019677 | ETOPOSIDE |
| 310011230 | 310005004 | 1.68 | 73.7 | Disease modification (D) | 2015-01-11 | 2015-01-28 | Cisplatin 100 + RT(H&N) 1 day | N | null | 310019686 | CISPLATIN + RT |
| 310011232 | 310005012 | 1.73 | 87 | Palliative (P) | 2016-06-30 | 2016-07-16 | Vinblastine | N | N | 310019697 | DABRAFENIB + TRAMETINIB |
| 310011233 | 310005024 | null | null | Neo-adjuvant (N) | 2014-12-03 | 2014-12-03 | Bortezomib + Cyclophos + Dex | N | null | 310019750 | TRIPLE INTRATHECAL |
| 310011234 | 310005039 | 1.59 | 61.9 | Palliative (P) | 2016-11-25 | 2016-12-02 | Cytarabine intrathecal | N | N | 310019827 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 310011235 | 310011284 | 1.73 | 90.3 | Palliative (P) | 2013-12-30 | 2015-02-09 | CISPLATIN + ETOPOSIDE | N | Y | 310019847 | CAPECITABINE + OXALIPLATIN |
| 310011236 | 310008201 | 1.73 | 94.6 | Palliative (P) | 2012-04-21 | 2014-12-05 | Methotrexate High Dose (3g/m2) | Y | N | 310019858 | METHOTREXATE HIGH DOSE |
| 310011237 | 310005054 | 1.63 | 48 | Disease modification (D) | null | 2017-02-05 | Everolimus 10mg | Y | N | 310019894 | CVP R + ETOPOSIDE |
| 310011238 | 310005060 | 1.62 | 73.2 | Palliative (P) | 2017-07-28 | 2017-09-07 | BCG Intravesical | N | N | 310019901 | FLUOROURACIL + RT |
| 310011239 | 310005065 | 1.57 | 50 | Not known (9) | 2018-12-21 | 2018-12-21 | RUXOLITINIB | 2 | N | 310019932 | AXITINIB |
| 310011240 | 310005071 | 1.59 | 60 | Palliative (P) | 2017-02-03 | 2017-02-08 | Olaparib | 02 | N | 310019962 | ATEZOLIZUMAB |
| 310011241 | 310005077 | 1.72 | 0 | Palliative (P) | 2014-05-01 | 2014-05-03 | Sunitinib | N | N | 310019978 | MERCAPTOPURINE + METHOTREXATE |
| 310011242 | 310008219 | 1.54 | 62.45 | Adjuvant (A) | 2019-08-11 | 2019-08-11 | Azacitidine | 02 | null | 310019991 | TRASTUZUMAB |
| 310011243 | 310011838 | 1.77 | 67.6 | Palliative (P) | 2016-01-02 | 2016-01-02 | Temozolomide 200mg/m2 | N | null | 310020008 | GEMCITABINE + OXALIPLATIN |
| 310011244 | 310011931 | null | 107.9 | Disease modification (D) | 2014-03-03 | 2014-04-06 | FLAG + Idarubicin | 2 | N | 310020015 | DABRAFENIB + TRAMETINIB |
| 310011245 | 310005094 | 0 | 8.3 | Adjuvant (A) | 2016-10-07 | 2016-10-07 | PEG INTERFERON | Y | N | 310020060 | DACARBAZINE |
| 310011246 | 310009883 | 1.8 | 104 | Palliative (P) | null | 2018-05-22 | Methotrexate High Dose (3g/m2) | N | N | 310020064 | EP |
| 310011247 | 310008233 | 1.59 | 76.4 | Adjuvant (A) | 2019-01-11 | 2019-01-11 | Doxorubicin + Olaratumab | N | Y | 310020087 | TOPOTECAN |
| 310011248 | 310005105 | null | 63.9 | Palliative (P) | 2014-08-08 | 2014-08-20 | Cisplatin + Liposomal Doxorubicin | N | N | 310020094 | PAZOPANIB |
| 310011249 | 310005107 | 1.74 | 48 | Disease modification (D) | 2013-10-12 | 2013-10-12 | BEAM + FLUDARABINE | N | N | 310020108 | MELPHALAN |
| 310011250 | 310005111 | 1.9 | null | Curative (C) | 2017-01-05 | 2017-01-05 | CISPLATIN + ETOPOSIDE | null | null | 310020124 | CISPLATIN + FLUOROURACIL + RT |
| 310011251 | 310005119 | 1.87 | 35.5 | null | 2015-07-18 | 2015-08-24 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 02 | N | 310020163 | IBRUTINIB |
| 310011252 | 310005123 | 1.61 | 54.7 | Palliative (P) | 2016-04-04 | 2016-07-02 | Alemtuzumab (Subcutaneous) | N | N | 310020170 | METHOTREXATE |
| 310011253 | 310005127 | null | 11.9 | Palliative (P) | 2014-06-04 | 2014-06-04 | BEP 5 Day | N | null | 310020176 | DACARBAZINE |